Interdisciplinary GU Cancer Forum 2025 Combination Therapies in prostate cancer, active surveillance, GG1 prostate cancer, radical prostatectomy.

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer oral abstract session and a presentation by Dr. Theodore DeWeese discussing a phase 3, randomized, placebo-controlled clinical ...

Interdisciplinary GU Cancer Forum 2025 Prostate Cancer, Artificial Intelligence in Molecular Targeted Imaging, ChatGPT by OpenAI, aPROMISE platform.

Interdisciplinary GU Cancer Forum 2025, Emerging Data and Advances in Prostate cancer Screening, Prostate cancer, homologous recombination repair (HRR), metastatic castration-resistant prostate cancer ...

Interdisciplinary GU Cancer Forum 2025, prostate cancer, de novo high-volume metastatic hormone-sensitive prostate cancer (mHSPC), Advances in Immunotherapy for prostate cancer, 177Lu-PSMA radioligand ...

Interdisciplinary GU Cancer Forum 2025, Prostate Cancer, Neoadjuvant Management of High-Risk Prostate Cancer, PROTEUS trial, GUNS trial, Genomic Umbrella Neoadjuvant Study, apalutamide, FOXA1 ...